Table:
begin	end	state
1	27	cytoplasmic
28	49	transmembrane
50	55	non-cytoplasmic
56	76	transmembrane
77	103	cytoplasmic
104	129	transmembrane
130	134	non-cytoplasmic
135	153	transmembrane
154	163	cytoplasmic
164	183	transmembrane
184	207	non-cytoplasmic
208	230	transmembrane
231	247	cytoplasmic
248	268	transmembrane
269	285	non-cytoplasmic
286	311	transmembrane
312	337	cytoplasmic
338	360	transmembrane
361	365	non-cytoplasmic
366	389	transmembrane
390	408	cytoplasmic
409	429	transmembrane
430	434	non-cytoplasmic
435	455	transmembrane
456	468	cytoplasmic

Input:
>GFF4621 FitnessBrowser__WCS417:GFF4621
MTTPDNGFAEITHRELGLRRQLTSGQMSMIAIGGAIGTGLFMGSAYAIGYAGPSVLVSYA
IGALITLLLMGCLAEMTVAHSTSGSFGAYAEFYISPLAGFLVRYAYWAAIVLAVGAEVTA
VAMYMKYWFANVPEWVWIVSFSSVLILLNAISVKTFGNFEYWFSTIKISAIVGFIILAVY
VVFGSGNPQYGVQNYTAHDGFFPHGLSGMWIAVIVSIFSYLSVEMIAVAAGEAADPEQAV
KKAFRATIVRLVVFYLLTLALMLAIVPWNQAGQAQSPFVTVMQTIGIPGATGVMNFVILI
AALSAMNSQLYITTRMMFSLSRAGFAPKSMGALSKNGIPLNALLLSSSGIALATLLNVVY
PESSFTLMMAISMFGAIFTWFMIFLTHLFFRRYRKRHGGPTLSFQLRLFPYSTLLGLVLM
GAVMVTTYFTEAFKMTLVFGVPFLLILSAVYYGFFRKGRAKASNKALA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server